The cognitive decline in Lewy Body Dementia emerges from a complex interplay of α-syn propagation, concomitant AD-like Aβ and tau pathology, and loss of neurotransmitter tone, which may work in an additive or synergistic manner. Here, MAPT is linked to Lewy body dementia.